Objective This systematic review aimed to answer the clinical question,“What is the current
risk of develo** osteoradionecrosis of the jaws among irradiated head and neck cancer …

Objective: To determine the risk factors, causes, therapies, and prevention measures for
head and neck cancer. Method: Risk factors, causes, therapies, and preventive measures for …

Background. Therapy for head and neck cancers has evolved over the past decade, but few
detailed analyses of recent developments in survival on the population level have been …

Background Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil
(PF) plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of the head and …

Purpose To investigate the impact of human papillomavirus (HPV) on the epidemiology of
oral squamous cell carcinomas (OSCCs) in the United States, we assessed differences in …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Head and Neck Cancers focuses on glottic laryngeal cancer, which is the most common …

Background About 10 000 persons are diagnosed as having carcinoma of the oral cavity or
the throat in Germany every year. Squamous-cell carcinoma accounts for 95% of cases …

Since the inception of this journal in 1948, the understanding of etiologic factors that
contribute to and the treatment of head and neck cancer has evolved dramatically. Advances …

Based on its potent capacity to induce tumor cell death and to abrogate clonogenic survival,
radiotherapy is a key part of multimodal cancer treatment approaches. Numerous clinical …

Background Radiotherapy (RT) is the chief nonsurgical method to control malignant tumors.
RT has advanced in both methodological and biological aspects over the past few decades …